Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer?
Gynecol Oncol
; 165(1): 60-66, 2022 04.
Article
en En
| MEDLINE
| ID: mdl-35140015
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Ováricas
/
Diabetes Mellitus Tipo 2
/
Metformina
Tipo de estudio:
Guideline
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Female
/
Humans
/
Male
Idioma:
En
Año:
2022
Tipo del documento:
Article